Change in Date of Anticipated Arbitration Decision in Sucampo Pharmaceuticals, Inc. Dispute
5/31/2012 10:24:15 AM
BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) announced today that the International Court of Arbitration, International Chamber of Commerce (ICC), has notified the Company of a change in the anticipated date of the arbitration decision related to its demand for arbitration under the applicable provisions of the Collaboration and License Agreement with Takeda Pharmaceuticals Company Limited, or Takeda. The ICC extended the date from May 31, 2012, to June 29, 2012. Sucampo does not know how long thereafter the proceedings will conclude.
comments powered by